Antiviral Activities of Interleukin-27: A Partner for Interferons?

Front Immunol. 2022 May 10:13:902853. doi: 10.3389/fimmu.2022.902853. eCollection 2022.

Abstract

Emergence of new, pandemic-level viral threats has brought to the forefront the importance of viral immunology and continued improvement of antiviral therapies. Interleukin-27 (IL-27) is a pleiotropic cytokine that regulates both innate and adaptive immune responses. Accumulating evidence has revealed potent antiviral activities of IL-27 against numerous viruses, including HIV, influenza, HBV and more. IL-27 contributes to the immune response against viruses indirectly by increasing production of interferons (IFNs) which have various antiviral effects. Additionally, IL-27 can directly interfere with viral infection both by acting similarly to an IFN itself and by modulating the differentiation and function of various immune cells. This review discusses the IFN-dependent and IFN-independent antiviral mechanisms of IL-27 and highlights the potential of IL-27 as a therapeutic cytokine for viral infection.

Keywords: antiviral immunity; infection; interferons; interleukin-27; viral immunology; virus.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Cytokines
  • Humans
  • Interferons
  • Interleukin-27*
  • Virus Diseases* / drug therapy

Substances

  • Antiviral Agents
  • Cytokines
  • Interleukin-27
  • Interferons